DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Ledermann JA, Harter P, Gourley C. et al.
Overall survival in patients with platinumsensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
Lancet Oncol 2016;
17: 1579-1589
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.